Status:
COMPLETED
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
Lead Sponsor:
Bayer
Conditions:
Menorrhagia
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether the levonorgestrel-releasing intrauterine system is effective in decreasing menstrual blood loss.
Detailed Description
Acronyms in the Adverse Event Section: * IUCD Intrauterine Contraceptive Device * MedDRA Medical Dictionary for Regulatory Activities This study has previously been posted by Berlex, Inc. and Scheri...
Eligibility Criteria
Inclusion
- Women who have \>/= 80 mL blood loss during their menstrual cycles and desire contraception
Exclusion
- Post menopausal menstrual cycle \< 21 days or \> 35 days
- Pregnancy
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT00360490
Start Date
July 1 2006
End Date
June 1 2008
Last Update
December 9 2013
Active Locations (54)
Enter a location and click search to find clinical trials sorted by distance.
1
Tucson, Arizona, United States, 85712
2
Beverly Hills, California, United States, 90211
3
Carmichael, California, United States, 95608
4
San Diego, California, United States, 92103